I 
119TH CONGRESS 
1ST SESSION H. R. 4396 
To direct the Secretary of Health and Human Services to study and report 
on the relationship between hair straighteners and uterine cancer, par-
ticularly among women of color. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 15, 2025 
Ms. CLARKE of New York (for herself, Ms. BROWN, Mrs. WATSON COLEMAN, 
Ms. KELLY of Illinois, Mr. DAVID SCOTT of Georgia, Ms. NORTON, Ms. 
SEWELL, Mrs. FOUSHEE, Ms. MCCLELLAN, Ms. VELA´ZQUEZ, Mr. 
FIELDS, Mrs. DINGELL, Ms. TLAIB, Mrs. TRAHAN, Mr. JOHNSON of 
Georgia, Ms. ANSARI, Mr. THANEDAR, Mr. THOMPSON of Mississippi, 
Mr. KRISHNAMOORTHI, Ms. SALINAS, Mrs. MCIVER, Mr. CARTER of Lou-
isiana, Ms. WILSON
of Florida, Ms. LEE
of Pennsylvania, Ms. 
WASSERMAN SCHULTZ, Mr. FIGURES, Ms. ADAMS, Mr. KHANNA, Mr. 
MEEKS, Mr. GREEN of Texas, Ms. TOKUDA, Ms. RIVAS, and Mr. 
MANNION) introduced the following bill; which was referred to the Com-
mittee on Energy and Commerce 
A BILL 
To direct the Secretary of Health and Human Services to 
study and report on the relationship between hair 
straighteners and uterine cancer, particularly among 
women of color. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
02:23 Jul 18, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4396.IH
H4396
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Uterine Cancer Study 
Act of 2025’’. 
SEC. 
2. 
STUDY 
ON 
RELATIONSHIP 
BETWEEN 
HAIR 
STRAIGHTENERS AND UTERINE CANCER. 
(a) STUDY.—The Secretary of Health and Human 
Services, in coordination with the Commissioner of Food 
and Drugs and the Director of the National Institutes of 
Health, shall conduct a study on the relationship between 
hair straighteners and uterine cancer, with a focus on the 
increased incidence of such cancer among women of color. 
Such study shall— 
(1) review significant findings and recommenda-
tions from other studies regarding the relationship 
between hair straighteners and uterine cancer; 
(2) consider impacts on women and other indi-
viduals at risk of uterine cancer from all racial and 
ethnic backgrounds; 
(3) disaggregate the results of the study under 
this section according to whether the hair straight-
eners contain dyes or coloring, bleach, highlights, or 
perms; and 
(4) determine whether the Food and Drug Ad-
ministration should impose additional testing re-
quirements on the manufacturers of hair straight-
VerDate Sep 11 2014 
02:23 Jul 18, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4396.IH
H4396
kjohnson on DSK7ZCZBW3PROD with $$_JOB
ening products to ensure the safety of such prod-
ucts. 
(b) METHODOLOGY.—Not later than 45 days after 
the date of enactment of this Act, the Secretary shall sub-
mit to the Committee on Energy and Commerce of the 
House of Representatives and the Committee on Health, 
Education, Labor, and Pensions of the Senate a descrip-
tion of the methodology that will be used to conduct the 
study under this section. 
(c) COMMENCEMENT.—Not later than 180 days after 
the date of enactment of this Act, the Secretary shall com-
mence the study under this section. 
(d) REPORT.—Not later than 2 years after the date 
of enactment of this Act, the Secretary shall complete the 
study under this section and submit to the Committee on 
Energy and Commerce of the House of Representatives 
and the Committee on Health, Education, Labor, and 
Pensions of the Senate a report on the results of such 
study. 
(e) DEFINITION.—In this section: 
(1) The term ‘‘hair straightener’’ means a 
chemical hair straightener. 
(2) The term ‘‘Secretary’’ means the Secretary 
of Health and Human Services. 
Æ 
VerDate Sep 11 2014 
02:23 Jul 18, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4396.IH
H4396
kjohnson on DSK7ZCZBW3PROD with $$_JOB